as 11-15-2024 4:00pm EST
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Founded: | 1946 | Country: | United States |
Employees: | N/A | City: | TEANECK |
Market Cap: | 682.5M | IPO Year: | 2014 |
Target Price: | $19.00 | AVG Volume (30 days): | 174.8K |
Analyst Decision: | Sell | Number of Analysts: | 3 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 0.43 | EPS Growth: | -15.74 |
52 Week Low/High: | $9.49 - $25.98 | Next Earning Date: | 11-06-2024 |
Revenue: | $1,046,762,000 | Revenue Growth: | 7.17% |
Revenue Growth (this year): | 21.75% | Revenue Growth (next year): | 12.67% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
CORCORAN E THOMAS | PAHC | Director | Sep 4 '24 | Buy | $20.02 | 5,000 | $100,100.00 | 25,000 |
PAHC Breaking Stock News: Dive into PAHC Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
Argus Research
5 days ago
Zacks
5 days ago
Zacks
5 days ago
Zacks
6 days ago
Zacks
9 days ago
Simply Wall St.
9 days ago
Thomson Reuters StreetEvents
9 days ago
The information presented on this page, "PAHC Phibro Animal Health Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.